Potential immune escape mechanisms underlying the distinct clinical outcome of immune checkpoint blockades in small cell lung cancer

Overview of attention for article published in Journal of Hematology & Oncology, June 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

news: 1 news outlet

twitter: 1 X user

Citations

dimensions_citation: 60 Dimensions

Readers on

mendeley: 78 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Chintan Shah, MD, on Updated Findings From IMPOWER133 in SCLC

MedPage Today, 19 Mar 2021

The IMPower133 trial brought good news to the small-cell lung cancer (SCLC) community: Phase III of the study, which ran from…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.